BUZZARD PHARMACEUTICALS AB
BUZZARD PHARMACEUTICALS AB
Industry:
Natural Resources
Founded:
2016-08-24
Address:
Solna, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.buzzardpharma.com
Status:
Active
Official Site Inspections
http://www.buzzardpharma.com
- Host name: 171.214.140.34.bc.googleusercontent.com
- IP address: 34.140.214.171
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Buzzard Pharmaceuticals AB"
BUZZARD PHARMACEUTICAL | Home
Buzzard Pharmaceuticals AB โข is based in Stockholm and was founded in 2016 by Urban Paulsson and Maarten de Château โข has a focus on developing drugs in oncologySee details»
Buzzard Pharmaceuticals AB - BIO CEO & Investor Conference | BIO
Feb 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ...See details»
Buzzard Pharmaceuticals AB - Crunchbase Company Profile
Buzzard Pharmaceuticals AB is a Pharmaceutical company. AI Content may contain mistakes and is not legal, financial or investment advice.See details»
Buzzard Pharmaceuticals AB - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Buzzard Pharmaceuticals AB of Stockholm, Stockholm. Get the latest business insights from Dun & โฆSee details»
Buzzard Pharmaceuticals - PitchBook
Buzzard Pharmaceuticals General Information Description. Developer of a pharmaceutical drug designed to be used for cancer treatment. The company is licensed with the rights to develop โฆSee details»
Buzzard Pharmaceuticals AB - Företagsinformation - allabolag.se
Buzzard Pharmaceuticals AB,559073-6855 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, adress mm för Buzzard Pharmaceuticals ABSee details»
Buzzard Pharmaceuticals - LinkedIn
Buzzard Pharmaceuticals | 247 followers on LinkedIn. Developing Isunakinra - a potent IL-1 inhibitor - as an Immuno-Oncology agent | Buzzard Pharmaceuticals is a biopharmaceutical โฆSee details»
Buzzard Pharmaceutical - VentureRadar
"Buzzard Pharmaceuticals AB has a focus on developing drugs in oncology. It has acquired the rights to isunakinra from Eleven Biotherapeutics in 2017 with the intent to re-position โฆSee details»
Buzzard Pharmaceuticals - SwedenBIO
Buzzard Pharmaceuticals AB is based at the Karolinska Institute Science Park in Stockholm and was founded in 2016 by Urban Paulsson and Maarten de Château. The company has โฆSee details»
Buzzard Pharmaceuticals AB:Company Profile & Technical โฆ
Buzzard Pharmaceuticals AB is a company that provides Natural resource management and more. Buzzard Pharmaceuticals AB is headquartered in Sweden .See details»
UEI G1GAEEDJG785 - Government Data Insights
UEI - Entity Report for G1GAEEDJG785 BUZZARD PHARMACEUTICALS AB. Unique Entity Identifier (UEI) G1GAEEDJG785: Corporate and Governmental Entity Code (Cage Code)See details»
Buzzard Pharmaceuticals AB - BioCentury Company Profiles - BCIQ
Sep 13, 2019 Buzzard Pharmaceuticals AB - BioCentury Company Profiles for the biopharma industrySee details»
Buzzard Pharmaceutical - VentureRadar
Buzzard Pharmaceuticals AB has a focus on developing drugs in oncology. It has acquired the rights to isunakinra from Eleven Biotherapeutics in 2017... ... Find out ...See details»
Overview, News & Similar companies - ZoomInfo.com
Www.buzzardpharma.com. Revenue $21.5 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. No recent news or media. Overview ; Who is Buzzard Pharmaceuticals. โฆSee details»
Simsen announces collaboration with Buzzard Pharmaceuticals
Feb 21, 2025 https://www.buzzardpharma.com. Contact: Pontus Rehn CEO, Simsen Diagnostics [email protected]. Recommended For You. Customer. 2 Min โฆSee details»
Buzzard Pharmaceuticals AB - Drug pipelines, Patents ... - Patsnap
Explore Buzzard Pharmaceuticals AB with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 1 news, and 2 literature, Disease Domain ...See details»
BUZZARD PHARMACEUTICAL | PIPELINE
A recent study shows that the combination of antiโIL-1ฮฒ with antiโPD-1 treatment improves the outcome of 4T1 mammary carcinoma in mice; Each modality on its own has a modest effect โฆSee details»
Buzzard Pharmaceuticals - Products, Competitors, Financials, โฆ
Buzzard Pharmaceuticals is a biopharmaceutical company focused on the development of drugs in the oncology sector. Use the CB Insights Platform to explore Buzzard Pharmaceuticals's full โฆSee details»
Maarten de Château, M.D., Ph.D. | Springer Lab
Buzzard Pharmaceuticals, CEO and Founder. Sixera Pharma, CEO. email [email protected]See details»
Buzzard Pharmaceuticals AB (Buzzard Pharmaceuticals AB) - ่ฏ็ฉ โฆ
ไบ่งฃBuzzard Pharmaceuticals AB (Buzzard Pharmaceuticals AB)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็2้กนไธดๅบ่ฏ้ช, 1็ฏๆฐ้ปๅ2็ฏๆ็ฎ๏ผ็พ็ ้ขๅ:่ฟ็ค๏ผๆๆฏๅนณๅฐ:้็ป่็ฝ๏ผ็ โฆSee details»